NCT03091192 2026-04-14Savolitinib vs. Sunitinib in MET-driven PRCC.AstraZenecaPhase 3 Active not recruiting60 enrolled 15 charts
NCT00579514 2026-04-07Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase NA Active not recruiting21,081 enrolled
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT06126159 2026-03-20MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular MarkersChang Gung Memorial HospitalPhase NA Active not recruiting44 enrolled